Glassman Wealth Services Cara Therapeutics, Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.67 - $3.33 $1,239 - $2,470	742 New	742 $1,000
Q2 2021 Aug 04, 2021	SELL	$12.38 - $29.19 $61 - $145	-5 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$15.07 - $21.71 $75 - $108	5 New	5 $0
Q4 2019 Feb 07, 2020	SELL	$16.11 - $25.98 $144 - $233	-9 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$18.28 - $26.91 $164 - $242	9 New	9 $0

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.